Pentadecapeptide · Synthetic gastric peptide
BPC-157
Pentadecapeptide for soft-tissue repair and gut integrity. The foundation of any recovery protocol.
- Half-life4 hours (subcutaneous)
- Dose range200–400 mcg/day · 4–8 week cycle
- Reconstituted stability28 days, 2–8 °C
- VerificationCOA included
Mechanism
How it works.
Stimulates angiogenesis, growth-factor expression (FGF, VEGF), and modulates the nitric-oxide pathway. Particularly active in soft-tissue repair and gut barrier function.
Research
What the research shows.
Animal models and limited human research show accelerated tendon, ligament, and muscle healing, plus protective effects on gut lining (NSAID-induced damage in particular). No clinically-significant adverse effects reported in research-grade dosing.
BPC-157 is a 15-amino-acid synthetic fragment of a protective protein found in human gastric juice. Research suggests broad cytoprotective and angiogenic effects across soft tissue, tendon, ligament, gut lining, and skin.
Subcutaneous injection localized near the affected tissue is the most-studied delivery route in the research literature.
Contraindications
When not to use.
Active malignancy (theoretical angiogenic concern); pregnancy and lactation (no data). Not for use during peri-operative window without clinician oversight.
Optimal pairings
Stacks well with.
Information is educational, derived from published research. Not medical advice. All compounds sold for research use only. Bloodwork and a clinical consultation should precede any new protocol.